The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination.

Glund, Stephan; Gan, Guanfa; Moschetti, Viktoria; Reilly, Paul; Honickel, Markus; Grottke, Oliver; Van Ryn, Joanne.
Clin Appl Thromb Hemost; 24(5): 724-733, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29534609